Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration signaled a sweeping shift in how cutting-edge therapies reach patients this month, unveiling regulatory flexibility for cell and gene therapies, modernizing …
FDA Clears Faster Path for Gene Cures as Rare Disease Breakthrough Arrives Read More
HARRISBURG, PA — Pennsylvania health officials moved to calm growing anxiety over childhood vaccinations on Thursday, reaffirming that there have been no changes to vaccine access, insurance coverage, or school …
Pennsylvania Reaffirms Childhood Vaccine Access as Misinformation Swirls Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has been added to the Nasdaq Biotechnology Index, a move that places the clinical-stage biopharmaceutical company among a select group …
Aclaris Joins Nasdaq Biotech Index, Marking Milestone for Clinical-Stage Firm Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Itvisma, a new adeno-associated virus vector-based gene therapy for spinal muscular atrophy, extending treatment eligibility to adults and children 2 …
FDA Greenlights First Gene Therapy for Older SMA Patients, Raising Hope Nationwide Read More
WASHINGTON, D.C. — A bipartisan coalition in Congress is moving to strengthen America’s biotechnology and biopharmaceutical manufacturing base with the introduction of the Biomanufacturing Excellence Act — a sweeping proposal …
New Bipartisan Push Aims to Secure U.S. Lead in Biotech Manufacturing Read More
PHILADELPHIA, PA — Latus Bio, Inc. unveiled a significant expansion of its artificial intelligence and machine learning program as the company pushes deeper into AI-driven AAV capsid and payload design. …
Biotech Breakthrough: Latus Bio Doubles Down on AI to Revolutionize Gene Therapy Read More
WAYNE, PA & HOOKSETT, NH — Argosy Healthcare Partners (AHP) announced a recapitalization and strategic partnership with Integrated Solutions for Benefits and Insurance Services (IS Benefits), a New Hampshire–based firm …
Argosy Healthcare Partners Backs IS Benefits in Strategic Recapitalization Deal Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) Office for Civil Rights has issued a nationwide letter reminding states that participation in the federal Vaccines for …
HHS Issues Guidance Reaffirming Religious Exemptions in Vaccines for Children Program Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has recommended lifting the voluntary clinical hold on Elevidys for ambulatory patients with Duchenne Muscular Dystrophy (DMD), following a thorough …
FDA Clears Path for Resumed Use of Elevidys Gene Therapy in Ambulatory DMD Patients Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration on Friday placed Sarepta Therapeutics’ gene therapy trials for limb girdle muscular dystrophy on clinical hold following the deaths of three patients …
FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure Read More